论文部分内容阅读
目的探讨急性生理与慢性健康(APACHEⅡ)评分在慢性阻塞性肺疾病急性加重期(AECOPD)患者预后评价中的应用价值。方法回顾性分析我院2012年7月至2014年6月收治的60例AECOPD患者的临床资料,对不同APACHEⅡ分数患者的病死率与插管率等进行观察。结果 APACHEⅡ评分<10分组患者病死率为10.0%,插管率为10.0%;10~19分组患者病死率为25.0%,插管率为12.5%;20~29分组患者病死率为50.0%,插管率为41.7%;≥30分组患者病死率为78.6%,插管率为64.3%,4组患者的病死率与插管率比较差异有统计学意义(P<0.05)。结论对于AECOPD患者来说,应用APACHEⅡ评分体系具备明显的临床效果,可以对患者预后情况进行有效预测。
Objective To investigate the value of acute physiology and chronic health (APACHEⅡ) score in the prognosis evaluation of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods The clinical data of 60 patients with AECOPD admitted to our hospital from July 2012 to June 2014 were retrospectively analyzed. The mortality and intubation rate of patients with different APACHEⅡ scores were observed. Results The mortality of patients with APACHEⅡ score <10 was 10.0% and the rate of intubation was 10.0%. The mortality of patients in 10-19 group was 25.0% and the rate of intubation was 12.5%. The mortality of patients in 20-29 group was 50.0% The mortality rate was 41.7%. The mortality rate was 78.6% and the intubation rate was 64.3% in ≥30 group. The mortality and intubation rate of four groups were significantly different (P <0.05). Conclusion For patients with AECOPD, the application of APACHE Ⅱ scoring system has obvious clinical effect, which can effectively predict the prognosis of patients.